Pioneering trial of a stem cell therapy begins

10/11/2010 | Wall Street Journal, The

The first patient has been recruited in a clinical trial that will assess the efficacy of a stem cell therapy derived from human embryos in the treatment of spinal cord injuries. The experimental treatment will be administered for 14 days.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN